Gene Therapy Market Research Reports & Industry Analysis
Gene therapy is an innovative field with the potential to develop new, personalized medical treatments for previously challenging conditions. At MarketResearch.com, we are committed to providing you with comprehensive gene therapy industry reports that shed light on this fast-growing market.
Understanding the Gene Therapy Market
- Our gene therapy market research reports provide valuable insights into this dynamic field to help you understand the key factors at play, prepare for challenges, and leverage technological advancements.
- Our research collection covers various markets—such as gene therapy, precision medicine, delivery devices, and manufacturing services—with data on market size and growth projections.
- In addition, we also delve into market segmentation, key developments, industry trends, and company profiling to give you the full picture of the market.
Helping You Stay Ahead
Whether you're an experienced industry professional, a consultant, or a busy executive, our gene therapy market research reports provide valuable insights. These reports are based on reliable data and expert analysis to help you make informed business decisions. With MarketResearch.com, you can stay ahead of the competition and take advantage of emerging market opportunities.
Gene Therapy Industry Research & Market Reports
-
Biopharmaceutical and Biomedicine Market, by Product Type (Biopharmaceutical, Nano medicine, Gene Therapy, Bioinformatics, and Molecular Enzymes & Kits Market), and by Region - Global Industry Insights, and Forecast, 2022 - 2028
... one of the key segments with immense growth potential in the healthcare sector. Rising demand for effective treatment and rise in per capita healthcare expenditure has led to double digit revenue growth for industry players ... Read More
-
Immunodeficiency Therapeutics Market, by Therapy Type (Immunoglobulin Therapy, Antibiotics Therapy, Stem Cell and Gene Therapy, and Others), by Test Type (Blood Test and Prenatal Testing), by Disease Type (Antibody Deficiency, Cellular Immunodeficiency, I
... and Others), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - ... Read More
-
Viral Vector and Plasmid DNA Manufacturing Market, by Product Type (Viral Vector, Plasma DNA, and Non-viral DNA Vectors), by Therapeutic Application (Cancer, Inherited Disorders, Infectious Diseases, and Others), by End Product (DNA Vaccines, Gene Therapy
... Immunotherapy, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Viral vectors aids in transferring genetic material into ... Read More
-
Gene Therapy for Rare Disease Market - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
... medicines with one or more indications approved under the Orphan Drug Act of 1983. The Orphan Drug Act supports the development of innovative treatments for rare disease patients. The creation of the orphan drug designation ... Read More
-
Bioreactors Market Size By Product Type (Single-use, Reusable), By Cell (Mammalian Cells, Bacterial Cells, Yeast Cells), By Molecule (Monoclonal Antibodies, Vaccines, Recombinant Proteins, Stem Cells, Gene Therapy), By Usage (Developmental, Pre-clinical & Clinical, Commercial Production), By End-use (R&D Organizations, Biopharma Manufacturers, Contract Manufacturing Organizations [CMOs]), Industry Analysis, Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2022 - 2030
... By End-use (R&D Organizations, Biopharma Manufacturers, Contract Manufacturing Organizations [CMOs]), Industry Analysis, Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2022 - 2030 The global bioreactors market is expected to gain ... Read More
-
Hemophilia Gene Therapy Market - Size, Share, Trends, and Forecast, 2022 - 2028
... factors. Conventional treatment options include timely replacement of the specific clotting factor. Major pharma and biotech companies are conducting research and development to develop gene therapy for hemophilia due to various shortcomings with conventional therapy. ... Read More
-
Cell Culture Market, by Product Type (Instruments and Consumables), by Application (Vaccine Production, Gene Therapy, Cancer Research, Tissue Culture, Drug Development, and Others), by End User (Academic & Research Institutions, and Pharmaceutical and Bio
... and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 The technique of growing cells outside the human body itself is ... Read More
-
Biologics Market, by Drug Class (Monoclonal Antibody, Vaccine, Recombinant Insulin, Human Growth Hormone, Blood Factor, Fusion Protein, Erythropoietin, Recombinant Enzyme, Interferon, Colony-stimulating Factor, Cell Therapy, Gene Therapy, Oligonucleotides
... by Therapeutic Application (Oncology, Metabolic Disorders, Autoimmune/Immunologic Diseases, Ophthalmic Diseases, Inflammatory Bowel Diseases (IBDs), Respiratory Disorders, Neurological Disorders, Musculoskeletal Disorders (MSDs), Cardiovascular Diseases (CVDs), Infectious Diseases, and Others), by Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, ... Read More
-
Cell and Gene Therapy Market - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
... can be autologous or allogeneic, which can be derived from stem cells such as bone marrow. Stem cells therapy is used in bone marrow transplantation. Gene therapy is the introduction, removal, or change in the ... Read More
-
Plasmid DNA Manufacturing Market, By Product Type (Viral Vectors (Retroviral, Adenoviral, Lentiviral, Adeno-Associated, Others), Plasmid DNA, Non-viral, Lipid/polymer, Electroporation, Nanoparticles, and Others), Â By Grade (GMP Grade and R&D Grade), By A
... Therapy, Immunotherapy, and Others), By Development Phase (Pre-Clinical Therapeutics, Clinical Therapeutics, and Marketed Therapeutics) By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 ... Read More
-
Global Cancer Gene Therapy Market Size, Share & Industry Trends Analysis Report By Therapy (Gene Induced Immunotherapy, Oncolytic Virotherapy, and Gene Transfer), By End User, By Regional Outlook and Forecast, 2022 - 2028
... Cancer Gene Therapy Market size is expected to reach $5 billion by 2028, rising at a market growth of 21.2% CAGR during the forecast period. Gene therapy is the process of replacing faulty or damaged ... Read More
-
North America Cancer Gene Therapy Market Size, Share & Industry Trends Analysis Report By Therapy (Gene Induced Immunotherapy, Oncolytic Virotherapy, and Gene Transfer), By End User, By Country and Growth Forecast, 2022 - 2028
... North America Cancer Gene Therapy Market would witness market growth of 19.6% CAGR during the forecast period (2022-2028). Cancer gene therapy is a strategy for treating cancer that involves inserting therapeutic DNA into the patient's ... Read More
-
Europe Cancer Gene Therapy Market Size, Share & Industry Trends Analysis Report By Therapy (Gene Induced Immunotherapy, Oncolytic Virotherapy, and Gene Transfer), By End User, By Country and Growth Forecast, 2022 - 2028
... Cancer Gene Therapy Market would witness market growth of 20.3% CAGR during the forecast period (2022-2028). Favorable government therapeutic laws would further enhance numerous prospects, resulting in the expansion of the cancer gene therapy market ... Read More
-
2022 Global Forecast for Cell & Gene Therapy Manufacturing Services (2023-2028 Outlook)-High Tech & Emerging Markets Report
... over 50 countries. The global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or ... Read More
-
Global Expression Vectors Market Size study, By Host Type (Bacterial Expression Vectors, Mammalian Expression Vectors, Insect Expression Vectors, Yeast Expression Vectors, Other Expression Vectors), By Application (Therapeutic Applications, Research Applications, Industrial Applications), By End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs) and Contract Manufacturing Organizations (CMOs), Academic Research Institutes, Other End Users), and Regional Forecasts 2022-2028
... (Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs) and Contract Manufacturing Organizations (CMOs), Academic Research Institutes, Other End Users), and Regional Forecasts 2022-2028 Global Expression Vectors Market is valued approximately USD 334.54 million in 2021 ... Read More
-
Gene Cloning Services Market - A Global and Regional Analysis: Focus on Service, Gene Type, Application, End User, and Region - Analysis and Forecast, 2021-2031
... (Gene Synthesis Service, Molecular Biology Service, Custom Cloning Service, and Other Service) Gene Type (Standard Gene, Complex Gene, and Other Gene Type) Application (Gene Synthesis, Gene Expression, Vaccine Research, Gene Therapy, and Other) End User ... Read More
-
Investor Series: Opportunities in the Cell and Gene Therapy Market
... the leading causes of death across the globe. In fact, the World Health Organization (WHO) has reported that close to 10 million deaths occur annually, due to cancer, across the world. Moreover, experts believe that ... Read More
-
Gene Therapy Market By Vector Type (Viral Vector, Non Viral Vector), By Therapy (In Vivo Therapy, Ex Vivo Therapy), By Gene Type (Antigen, Cytokine, Tumor Suppressor, Suicide, Deficiency, Growth factors, Receptors, Others), By Application (Oncological Disorders, Rare Diseases, Neurological Disorders, Other Diseases): Global Opportunity Analysis and Industry Forecast, 2020-2030
... Disorders, Rare Diseases, Neurological Disorders, Other Diseases): Global Opportunity Analysis and Industry Forecast, 2020-2030 Genes are composed of DNA that contains the necessary information to produce proteins that are vital for the human body to ... Read More
-
Gene Therapy Market (Product: Instruments, Media, Sera, and Reagents; and End-user: Biotechnology Companies, Pharmaceutical Companies, Academic Institutes, and Research Institutes) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028
... Scope of Report TMR’s report on the global gene therapy market studies the past as well as current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast ... Read More
-
Spinal Muscular Atrophy (SMA) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Spinal Muscular Atrophy (SMA) (Central Nervous System) pipeline landscape. Spinal muscular atrophy (SMA) is a ... Read More
-
Gene Therapies & Associated Vectors: Intellectual Property Landscape
... gene therapy was in 1990, to treat adenosine deaminase (ADA) deficiency related severe combined immunodeficiency (SCID). Briefly, a replication defective retrovirus was used to transfect autologous T-cells with a functional copy of the ADA gene, ... Read More
-
U.S. Gene Therapy Market - Industry Outlook & Forecast 2022-2027
... to the increased availability of funding from various public and private institutes. In addition, there is increased support from regulatory bodies for product approvals and providing fast-track designations to the products, which encourages vendors to ... Read More
-
Middle East and Asia Pacific Cell and Gene Therapy Market, by Therapy Type (Cell Therapy (Stem Cells, T Cells, Dendritic Cells, and NK Cells) and Gene Therapy (Germline Gene Therapy and Somatic Gene Therapy)), by Indication (Dermatology, Musculoskeletal, Oncology, Immunology, Cardiology & Neurology, and Others), by Technology (Lentiviral Vector, Plasmid DNA, and AAV), and by Region (Middle East and Asia Pacific) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028
... Indication (Dermatology, Musculoskeletal, Oncology, Immunology, Cardiology & Neurology, and Others), by Technology (Lentiviral Vector, Plasmid DNA, and AAV), and by Region (Middle East and Asia Pacific) - Size, Share, Outlook, and Opportunity Analysis, 2021 - ... Read More
-
Global Cell and Gene Therapy Related Products Market 2022-2028
... re-injected into the patient. Cell and gene therapies have the potential to address complex diseases, such as motor neurone disease, and many rare disorders for which there are no effective treatments. According to market research ... Read More
-
Global Cell and Gene Therapy Market 2022-2028
... Projected to expand at a CAGR of 28.2% from 2022 to 2028, the global cell and gene therapy market will worth USD 21,508 million by 2028-end, according to Gen Consulting Company. The report provides in-depth ... Read More
Research Assistance
